review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Jason K. Rivers | Q50419579 |
P2093 | author name string | R D Evans | |
A W Kopf | |||
R J Friedman | |||
R S Bart | |||
R A Lew | |||
D S Rigel | |||
P2860 | cites work | Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high-risk populations | Q26323265 |
Sunburn and malignant melanoma | Q35991952 | ||
Oral contraceptive use and malignant melanoma in Australia | Q35991966 | ||
Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors | Q35992011 | ||
Sunburn, suntan and the risk of cutaneous malignant melanoma--The Western Canada Melanoma Study | Q35992404 | ||
The aetiological significance of sunlight and fluorescent lighting in malignant melanoma: a case-control study | Q35992603 | ||
Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study | Q35992747 | ||
Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources | Q36027350 | ||
Racial differences in melanoma incidence | Q36043285 | ||
Variation of melanoma incidence with latitude in North America and Europe | Q36043508 | ||
A case-control study of the possible association between oral contraceptives and malignant melanoma | Q36045152 | ||
Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland | Q36047210 | ||
Malignant melanoma and oral contraceptive use among women in California | Q36069442 | ||
Immunology and photocarcinogenesis. New light on an old problem | Q39477739 | ||
Some environmental and bodily characteristics of melanoma patients. A case-control study | Q41493872 | ||
Confidence intervals | Q42032069 | ||
DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum | Q42461615 | ||
Malignant melanoma among employees of Lawrence Livermore National Laboratory | Q45932966 | ||
Diazepam and malignant melanoma | Q51864403 | ||
Correcting for variable age of onset in the estimation of familial relative risk when there is a secular trend in incidence of disease. | Q52871542 | ||
Prevalence of Nevocytic Nevi on Lateral and Medial Aspects of Arms | Q53984040 | ||
Further evidence for increased light sensitivity in patients with malignant melanoma. | Q54601395 | ||
P6195 | funding scheme | grant | Q230788 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | skin cancer | Q192102 |
P5008 | on focus list of Wikimedia project | Wikimedia–NIOSH collaboration | Q104416361 |
P304 | page(s) | 393-408 | |
P12526 | performing organization | New York University | Q49210 |
P577 | publication date | 1988-04-01 | |
P1433 | published in | The Journal of dermatologic surgery and oncology | Q27711471 |
P859 | sponsor | National Institute for Occupational Safety and Health | Q60346 |
P1476 | title | Risk factors for the development of malignant melanoma--I: Review of case-control studies | |
P478 | volume | 14 |
Q42499646 | A local education campaign on early diagnosis of malignant melanoma |
Q30794677 | Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data |
Q42011672 | Age and malignant melanoma: comparison of variables in different age-groups. |
Q41708855 | American College of Preventive Medicine practice policy statement: skin protection from ultraviolet light exposure. The American College of Preventive Medicine |
Q40559249 | An overview of skin cancers. Incidence and causation |
Q35591678 | Association between posterior uveal melanoma and iris freckles, iris naevi, and choroidal naevi |
Q47738627 | Barriers to sun safety in a Canadian outpatient population |
Q42487406 | Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications |
Q68033793 | Clinical features of dysplastic nevi |
Q35735127 | Clinical presentations of cutaneous melanoma |
Q73260225 | Dermatological perspectives of malignant melanoma |
Q42115012 | Does a history of melanoma correlate with the clinical presentation of dysplastic nevi? |
Q34696530 | Early detection of melanoma: the best strategy for a favorable prognosis |
Q37910861 | Effects of ultraviolet radiation |
Q43670535 | Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates |
Q34067597 | Epidemiology of melanoma |
Q50876216 | Facultative skin pigmentation in caucasians: an objective biological indicator of lifetime exposure to ultraviolet radiation? |
Q40777075 | Interaction between chemicals and melanin |
Q35684000 | Is there more than one road to melanoma? |
Q41285112 | Malignant melanoma from the dermatologic perspective |
Q33583862 | Malignant melanoma of the skin among workers in a telecommunications industry: mortality study 1976-83 |
Q43166521 | Malignant melanoma: girding our loins again |
Q35735559 | Melanoma of the head and neck: current concepts in staging, diagnosis, and management |
Q33607704 | Melanoma risk factors and atypical moles. |
Q40598230 | Melanoma, melanocytic nevi, and other melanoma risk factors in children |
Q36849880 | Models and mechanisms in malignant melanoma |
Q52078501 | Modified Karhunen-Loéve expansion for evaluating skin-colour-associated melanoma risk factors. |
Q34314780 | Occupation and the risk of malignant melanoma |
Q41098860 | Oral contraceptive use and risk of cutaneous malignant melanoma |
Q37380135 | Pharmacologic induction of epidermal melanin and protection against sunburn in a humanized mouse model |
Q40354356 | Precursors to melanoma and their mimics: nevi of special sites |
Q48649441 | Prevalence of common and dysplastic naevi in a Swedish population |
Q41713870 | Principles and guidelines for surgeons: management of cutaneous malignant melanoma. European Society of Surgical Oncology Brussels |
Q41860867 | Public awareness of malignant melanoma risk factors in Germany |
Q40559253 | Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? |
Q47608622 | Public health responses for skin cancer prevention: the policy framing of Sun Safety in Australia, Canada and England |
Q34053981 | Relationship between risk factors, knowledge and preventive behaviour relevant to skin cancer in general practice patients in south Australia |
Q61183033 | Risk of melanoma among radiologic technologists in the United States |
Q36134555 | Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden |
Q40789055 | Second primary tumors in patients with cutaneous malignant melanoma |
Q41439538 | Skin Types in Dysplastic Nevus Syndrome |
Q28203994 | Skin cancer and ultraviolet-B radiation under the Antarctic ozone hole: southern Chile, 1987-2000 |
Q23919150 | Skin cancer prevention and detection practices in a Michigan farm population following an educational intervention |
Q35748087 | Strategies for skin cancer prevention |
Q50776123 | Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. |
Q35993025 | The detection and management of dysplastic nevi and early melanoma |
Q40069188 | The prevalence of melanocytic naevi among schoolchildren in South Hungary. |
Q33546828 | Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now? |
Q35146567 | Ultraviolet radiation and cutaneous malignant melanoma |
Q48948108 | Uptake of 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene in melanin-containing tissues |
Search more.